Alnylam Pharmaceuticals
ALNY
#643
Rank
โ‚ฌ30.35 B
Marketcap
231,62ย โ‚ฌ
Share price
-1.30%
Change (1 day)
67.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company